Lucine Lehmann

646 total citations
10 papers, 509 citations indexed

About

Lucine Lehmann is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Lucine Lehmann has authored 10 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Lucine Lehmann's work include Diabetes Treatment and Management (8 papers), Diabetes Management and Research (8 papers) and Metabolism, Diabetes, and Cancer (4 papers). Lucine Lehmann is often cited by papers focused on Diabetes Treatment and Management (8 papers), Diabetes Management and Research (8 papers) and Metabolism, Diabetes, and Cancer (4 papers). Lucine Lehmann collaborates with scholars based in United States, Denmark and United Kingdom. Lucine Lehmann's co-authors include John B. Buse, Bruce W. Bode, Ildiko Lingvay, Pedro Alberto García-Hernández, Paul Norwood, Mads Jeppe Tarp-Johansen, Federico Pérez Manghi, Louis Chaykin, J.P. Courrèges and Yehuda Handelsman and has published in prestigious journals such as JAMA, Diabetologia and Diabetic Medicine.

In The Last Decade

Lucine Lehmann

10 papers receiving 487 citations

Peers

Lucine Lehmann
Miles Fisher United Kingdom
Jamie Scism‐Bacon United States
Hailing Guo Germany
Isaac Sinay Argentina
Lucine Lehmann
Citations per year, relative to Lucine Lehmann Lucine Lehmann (= 1×) peers Haysook Choi

Countries citing papers authored by Lucine Lehmann

Since Specialization
Citations

This map shows the geographic impact of Lucine Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucine Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucine Lehmann more than expected).

Fields of papers citing papers by Lucine Lehmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucine Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucine Lehmann. The network helps show where Lucine Lehmann may publish in the future.

Co-authorship network of co-authors of Lucine Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of Lucine Lehmann. A scholar is included among the top collaborators of Lucine Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucine Lehmann. Lucine Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Buse, John B., Pedro Alberto García-Hernández, Mads Jeppe Tarp-Johansen, et al.. (2020). Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial. UNC Libraries. 8 indexed citations
2.
Vilsbøll, Tina, Thomas Blevins, Esteban Jódar, et al.. (2019). Fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin. Diabetes Obesity and Metabolism. 21(6). 1506–1512. 14 indexed citations
3.
Pieber, Thomas R., Steven P. Marso, Darren K. McGuire, et al.. (2017). DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality. Diabetologia. 61(1). 58–65. 111 indexed citations
4.
Norwood, Paul, Roger Chen, Elmar Jaeckel, et al.. (2017). Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide ( IDegLira ) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used. Diabetes Obesity and Metabolism. 19(11). 1562–1569. 2 indexed citations
6.
Lingvay, Ildiko, Federico Pérez Manghi, Pedro Alberto García-Hernández, et al.. (2016). Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes. JAMA. 315(9). 898–898. 168 indexed citations
8.
Buse, John B., Federico C. Pérez Manghi, Pedro Alberto García-Hernández, et al.. (2015). 23. Insulin Degludec/Liraglutide (IDegLira) Is Superior to Insulin Glargine (IG) in A1c Reduction, Risk of Hypoglycemia, and Weight Change: DUAL V Study (166-OR). 13(3). 78–79. 6 indexed citations
9.
Nelson, Harold S., Lucine Lehmann, & Michael S. Blaiss. (2012). Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet. Current Medical Research and Opinion. 28(6). 1043–1051. 7 indexed citations
10.
Bechard, Lori J., et al.. (1999). RESTING ENERGY EXPENDITURE (REE) IS ATTENUATED IN A PEDIATRIC BONE MARROW TRANSPLANT (BMT) PATIENT. Journal of Pediatric Gastroenterology and Nutrition. 29(4). 514–514. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026